ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Overview of New "Don't Eat Me" Target CD24 Research Zhaoruijie/PharmaSources
July 03, 2023Recently, Antengene Corporation announced that the Phase I clinical trial application (IND) of its global first anti-CD24 monoclonal antibody, ATG-031, had been approved by FDA.
Pharma Sources Insight January 2025
